Date published: 2026-2-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC646576 Inhibitors

LOC646576 inhibitors refer to a class of chemical compounds designed to selectively bind to and inhibit the activity of a specific biological target identified by the placeholder name LOC646576. This biological target is typically a protein or enzyme that plays a critical role in a particular biochemical pathway within cells. The mechanism of action for inhibitors in this class involves the stabilization of the target in an inactive form, preventing the normal catalytic or signaling functions that the protein typically carries out. The specificity of LOC646576 inhibitors is a result of their molecular structure, which is often meticulously designed to fit into the active site or a regulatory region of the LOC646576 protein, much like a key fits into a lock.

The development of LOC646576 inhibitors requires an in-depth understanding of the structure and function of the LOC646576 protein, which typically involves techniques such as x-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, or cryo-electron microscopy to ascertain the three-dimensional configuration of the target molecule. Once the structural details are known, medicinal chemists use this information to design inhibitors that exhibit high affinity and selectivity for LOC646576. The inhibitors might mimic the shape and charge distribution of the natural substrate of the enzyme or interact with specific amino acids that are essential for the biological activity of the protein. The design process often includes the use of computational methods like molecular docking and structure-based drug design to predict how the inhibitors will interact with LOC646576 and to refine their structures for optimal interactions before they are synthesized and tested in vitro and in vivo to determine their efficacy in modulating the function of LOC646576.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and prevents the transcription process, which may reduce the expression of HHIP antisense RNA 1.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin inhibits RNA polymerase II, which is responsible for transcribing mRNA, and could also affect non-coding RNA transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This compound incorporates into DNA and RNA and inhibits DNA methyltransferase, potentially altering HHIP antisense RNA 1 expression.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin can inhibit bacterial RNA polymerase, and although not directly applicable to human RNA, it indicates a potential for polymerase inhibition.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide has been shown to inhibit the transcription of various RNAs by targeting multiple transcription factors.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB inhibits RNA polymerase II by blocking the initiation and elongation stages of transcription.

Isoquinoline

119-65-3sc-255224
sc-255224A
5 g
100 g
$26.00
$58.00
(0)

Isoquinoline and its derivatives can intercalate in DNA, possibly affecting the transcription of certain RNAs.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin terminates RNA chain elongation due to its structure as an adenosine analog.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Leptomycin B inhibits the export of RNA from the nucleus, which could indirectly affect RNA stability and expression levels.

Bisphenol A

80-05-7sc-391751
sc-391751A
100 mg
10 g
$300.00
$490.00
5
(0)

Bisphenol A can interfere with various nuclear receptors, potentially altering gene expression profiles including non-coding RNAs.